OnabotulinumtoxinA: A Review in the Prevention of Chronic Migraine.

about

OnabotulinumtoxinA in the treatment of refractory chronic cluster headache.Polypharmacy Among Headache Patients: A Cross-Sectional Study

P2860

Q55417882-285C90F7-5617-496A-A39B-F9E82FC08E57 Q58896340-F9E553AC-6D96-4EC4-A4FE-605FF7AE1F5E

P2860

OnabotulinumtoxinA: A Review in the Prevention of Chronic Migraine.

Item

http://www.wikidata.org/entity/Q52658935

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

OnabotulinumtoxinA: A Review in the Prevention of Chronic Migraine.

@en

OnabotulinumtoxinA: A Review in the Prevention of Chronic Migraine.

@nl

type

Item

label

OnabotulinumtoxinA: A Review in the Prevention of Chronic Migraine.

@en

OnabotulinumtoxinA: A Review in the Prevention of Chronic Migraine.

@nl

prefLabel

OnabotulinumtoxinA: A Review in the Prevention of Chronic Migraine.

@en

OnabotulinumtoxinA: A Review in the Prevention of Chronic Migraine.

@nl

P1476

OnabotulinumtoxinA: A Review in the Prevention of Chronic Migraine.

@en

P2093

James E Frampton

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Botulinum Toxin Type a as a Therapeutic Agent against Headache and Related Disorders

Treatment of Chronic Migraine with OnabotulinumtoxinA: Mode of Action, Efficacy and Safety

Development of onabotulinumtoxinA for chronic migraine

The diagnosis and treatment of chronic migraine

EFNS guideline on the drug treatment of migraine--revised report of an EFNS task force

Extracranial injections of botulinum neurotoxin type A inhibit intracranial meningeal nociceptors' responses to stimulation of TRPV1 and TRPA1 channels: Are we getting closer to solving this puzzle?

The International Classification of Headache Disorders: 2nd edition

Italian guidelines for primary headaches: 2012 revised version

Prospective analysis of the use of OnabotulinumtoxinA (BOTOX) in the treatment of chronic migraine; real-life data in 254 patients from Hull, U.K.

OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program.

P2888

s40265-018-0894-6

P304

589-600

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1007/S40265-018-0894-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Stephen D. Silberstein

P5008

ScienceSource

P577

2018-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29532439

http://www.w3.org/2001/XMLSchema#string

P921

migraine disorder

bacterial protein

Anzim

P932

5915521

http://www.w3.org/2001/XMLSchema#string

OnabotulinumtoxinA: A Review in the Prevention of Chronic Migraine.

about

P2860

P2860

OnabotulinumtoxinA: A Review in the Prevention of Chronic Migraine.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P433

P478

P50

P5008

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P433

P478

P50

P5008

P577

P698

P921

P932